HIV Clinical Trial
Official title:
HLA and KIR Associations With Infectious Viral Agents in an HIV Cohort of Women (WIHS)
Since the beginning of the HIV/AIDS epidemic, the number of women infected with HIV has
rapidly increased and is continuing to climb. The Women's Interagency HIV Study is being
conducted in several cities in the United States to learn more about how HIV affects women's
lives and bodies. It will examine the role of HLA and killer immunoglobulin-like receptors
(KIR) in HIV and related infections in HIV-positive and HIV-negative women. The study will
determine the relationship between KIR and HLA genes and the following: the risk of HIV
infection; HIV levels in the blood; incidence of AIDS; response to highly active
antiretroviral therapy (HAART); and response to immunotherapy.
Approximately 3,700 women will participate. Participants will visit the clinic every 6 months
for 4 years. An HIV test will be given each time to HIV-negative women. A questionnaire will
also be administered. A physical examination and gynecological examination will be given.
Blood, vaginal swabs, and urine will be collected for testing. A biological impedance test
will determine any changes in weight, waist-to-hip ratios, and breast and total body fat. Low
CD4 counts and hospitalizations for HIV are to be self-reported to study staff.
The aim of the study is to examine the role of HLA and killer immunolobulin-like receptors
(KIR) in the natural history of HPV, HCV, and HBV in HIV-positive and HIV-negative women. The
immune response to viral infection mediated by T lymphocytes is HLA restricted, suggesting
that HLA class I, and class II might be associated with risk of viral infection, persistence
and disease progression. Natural killer (NK) cells are a unique group of lymphocytes involved
in surveillance and killing of foreign or infected cells through a mechanism involving
recognition of HLA molecules by an extremely diverse set of receptors on the NK cell surface.
A major group of these receptors are the KIRs. Thus, a relationship between KIR genotype and
HIV infection is biologically plausible, and requires further investigation in observational
studies.
The WIHS study is a prospective study, which may allow us to answer questions relating to the
role of host HLA and KIR genotype on duration of infection, and the development of
virus-associated diseases such as cervical cancer (related to HPV infection), and liver
cancer (HBV and HCV). WIHS is a large, racially and geographically diverse cohort of HIV
positive (n = 2761), and risk-matched HIV-negative women (n = 942). The large size of the
cohort will provide substantial statistical power, which is of major importance in any HLA
association study.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
| Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
| Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
| Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
| Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
| Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
| Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
| Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
| Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
| Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
| Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
| Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
| Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
| Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
| Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
| Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
| Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
| Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
| Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |